Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2023

Mar 11, 2023

34576_dirs_2023-03-10_573787d6-4006-46dd-acc0-84af6cb02bb9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-03-08

Reporting Person: Graham Juan (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-08 Common Stock S 2749 $21.1559 Disposed 70213 Direct
2023-03-08 Common Stock A 2899 $0.00 Acquired 73112 Direct
2023-03-08 Common Stock A 4668 $0.00 Acquired 77780 Direct
2023-03-10 Common Stock S 1112 $20.1973 Disposed 76668 Direct
2023-03-10 Common Stock S 1456 $20.1973 Disposed 75212 Direct
2023-03-10 Common Stock S 2344 $20.1973 Disposed 72868 Direct

Footnotes

F1: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

F2: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.

F3: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023

F4: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.

F5: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.